You closed the operation, sent the PIX, and now you wait. Minutes become hours. You message support and get a "processing". When the asset finally arrives, the market price has already changed, the opportunity window has closed, and the supplier you needed to pay is still waiting.
This scenario is more common than it should be in the Brazilian OTC market. And most companies that go through it believe it's part of the process — that "it's just how it is". It isn't.
"Every OTC promises speed on their website. Few can answer precisely how long settlement takes by asset and volume."
There are two types of reason for an OTC to delay settlement. Knowing the difference is the first step to choosing better.
Blockchain block confirmations, fraud verification for volumes above limits, compliance for risk-profile operations. When these exist, a serious OTC informs before closing — not after.
The platform uses the gap between receiving your PIX and sending the asset — the so-called float — to operate in the market on its own account. This creates a direct conflict of interest and is rarely disclosed.
If the OTC cannot answer precisely how long settlement takes by asset type and volume, the commercial float is the most likely explanation.
Many companies don't quantify the cost of delays because it shows up in indirect ways. But it's real and cumulative.
Price variation risk. USDT and USDC are stable, but BTC isn't. An operation that takes 4 hours to settle in BTC exposes the company to a movement that may exceed the operation's own spread. You paid for predictability and ended up with risk.
Payment flow disruption. If crypto is used to pay an international supplier, every hour of delay can mean contractual penalties, missed deadlines, or the need for a second conventional FX operation — more expensive and slower — to cover the gap.
Invisible opportunity cost. The PIX has already left your account. The asset hasn't arrived yet. In that gap, capital isn't in a useful place — neither in BRL nor in crypto. For companies moving significant volume, this accumulated dead time over the month is measurable.
A company doing 20 operations per month with a 2-hour average delay is losing 40 hours of productive capital every month. Calculated against the volume operated, that cost is rarely zero.
Before closing your first operation with any platform, observe these indicators:
An SPSAV in the BACEN authorization process operates under Joint Resolution 13/2024, which requires segregation between own and client resources. In practice, this means the platform cannot use your asset as collateral for its own operations while processing your settlement.
This regulatory requirement eliminates the main commercial incentive to delay. When the OTC can't profit from the float, it has every interest in settling as quickly as possible — because a satisfied client operates more, at higher volume, and refers others.
Regulation and settlement speed are directly connected. It's not a coincidence — it's a consequence of the incentive alignment that regulation imposes.
If you already operate with a platform and are dissatisfied with settlement time, these are the right questions to ask before deciding to switch:
An OTC that can't answer these questions clearly is telling you, indirectly, that the delay won't improve.